These side effects had been notably milder as compared to an inhibitor of both bromodomains. An in depth molecular Investigation also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies give paradigms for potential clinical trials in AML, and the https://abbv-744drugdevelopmentpr91346.wizzardsblog.com/31887361/abbv-744-in-combination-with-immunotherapy-an-overview